Results 91 to 100 of about 2,049,710 (211)
Mucopolysaccharidosis type IIIC (MPSIIIC) is a severe lysosomal storage disease caused by deficiency in activity of the transmembrane enzyme heparan-α-glucosaminide N-acetyltransferase (HGSNAT) that catalyses the N-acetylation of α-glucosamine residues ...
Sara Marcó +14 more
doaj +1 more source
Chitosan-Hyaluronic acid hybrid vectors for retinal gene therapy [PDF]
info:eu-repo/semantics ...
Bitoque, Diogo +2 more
core
Preclinical animal models are indispensable for uncovering disease mechanisms and developing novel therapeutic interventions in synucleinopathies. Key readouts including neuronal cell death, neuroinflammation and alpha-synuclein protein aggregation, are ...
A. Barber-Janer +7 more
doaj +1 more source
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
Reetta A. E. Eriksson +16 more
doaj +1 more source
Impact of rapid mecA polymerase chain reaction rapid diagnostic testing for Staphylococcus aureus in a pediatric setting [PDF]
Rapid molecular technology can detect the mecA resistance gene in Staphylococcus aureus (SA), predicting methicillin susceptibility in under one hour. In combination with antimicrobial stewardship program interventions in adults with SA bacteremia, rapid
Drwiega, Emily
core +1 more source
Ewing’s sarcoma is the second most common malignant tumor of the bone occurring in children and adolescents. Typically, patients present between the ages of 10 and 20, with the disease having a slight predilection for males.1 Tumors often arise in the ...
Fenderson, PhD, Bruce A. +1 more
core +1 more source
Exploring RNA-targeted gene therapy approaches for hypertrophic cardiomyopathy [PDF]
Relatório de projeto no âmbito do Programa de Bolsas Universidade de Lisboa/Fundação Amadeu Dias (2011/2012). Universidade de Lisboa.
Freitas, Ana
core
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Adeno-associated virus (AAV) has emerged as a pivotal delivery tool in clinical gene therapy owing to its minimal pathogenicity and ability to establish long-term gene expression in different tissues.
Jiang-Hui Wang +4 more
doaj +1 more source
The Development of Regulatory Standards for Gene Therapy in the European Union [PDF]
This note examines the EU\u27s efforts to regulate gene therapy, considering the Union\u27s resolve to establish scientifically, economically, and morally sound parameters acceptable to its varied constituency.
De Jager, Charles F.
core +1 more source

